Friday 9/28 Insider Buying Report: HZNP, ROVI Friday, September 28, 12:22 PM ET
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.
At Horizon Pharma (NASDAQ:HZNP), a filing with the SEC revealed that on Tuesday, Director Jeffrey W. Bird bought 575,356 shares of HZNP, at a cost of $3.49 each, for a total investment of just over $2 million. Horizon Pharma is trading up about 2.6% on the day Friday.
And also on Tuesday, CEO Tom Carson purchased $225,000 worth of Rovi (ROVI), purchasing 15,000 shares at a cost of $15.00 a piece. This purchase marks the first one filed by Carson in the past twelve months. Rovi is trading up about 0.6% on the day Friday. Bargain hunters can bag ROVI at a price even lower than Carson did, with shares trading as low as $14.25 at last check today -- that's 5.0% under Carson's purchase price.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.